Cite
HARVARD Citation
Schram, A. et al. (n.d.). Identifying FGFR2 fusions/rearrangements in cholangiocarcinoma patients using a novel cfDNA algorithm for treatment with RLY-4008, a highly selective irreversible FGFR2 inhibitor. European journal of cancer. pp. S116-. [Online].